🥕 REVIVO BioSystems is making an impact in 𝗙𝗼𝗼𝗱 𝗧𝗲𝗰𝗵! 🧫 A recent study from Thailand utilized our 𝗥𝗲𝗹𝗲𝗚𝗢 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝗙𝗿𝗮𝗰𝘁𝗶𝗼𝗻 𝗖𝗼𝗹𝗹𝗲𝗰𝘁𝗼𝗿 for an 𝗲𝘅 𝘃𝗶𝘃𝗼 𝗴𝘂𝘁 𝗽𝗲𝗿𝗺𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝘀𝘁𝘂𝗱𝘆 on an active food ingredient, the Phayom flowers. 💡 The findings, showing 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘁 𝗮𝗯𝘀𝗼𝗿𝗽𝘁𝗶𝗼𝗻 𝗼𝗳 𝗯𝗲𝗻𝗲𝗳𝗶𝗰𝗶𝗮𝗹 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱𝘀, highlight how our technology provides crucial insights into the 𝗯𝗶𝗼𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗼𝗳 𝗻𝗮𝘁𝘂𝗿𝗮𝗹 𝗶𝗻𝗴𝗿𝗲𝗱𝗶𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 and wellness products. Please contact us if you want to learn more ! #microfluidics #permeation #biotech #Revivobiosystems
About us
REVIVO BioSystems specializes in 4D Human Skin models. Our capabilities are the closest commercially available to real human skin. We demonstrated superior morphology and barrier properties at the 3D skin tissue: external environment interface, and the ability to simulate blood flow (4D). This allows skin testing services in an accurate and efficient way. REVIVO BioSystems is founded by a team of engineers and biologists, with many years of experience in biomedical engineering, cell cultures, microfluidics and tissue engineering. Aiming to become the Asian and global leading provider of enabling technologies and services for ex vivo and in vitro testing of chemicals, ingredients, cosmetic formulations and therapeutics, our goal is to deliver products and services with unmatched quality, consistency, reproducibility, and ease-of-use. Our novel platforms enable realistic studies and cost enhancement versus other models and traditional methods.
- Website
-
https://www.revivobio.com
External link for REVIVO BioSystems
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Singapore
- Type
- Privately Held
- Founded
- 2019
- Specialties
- organtypic cultures, skin, cosmetics, skin testing, organs-on-a-chip, in vitro testing, skin-on-chip equivalents, microfluidics, and ex vivo testing
Locations
-
Primary
Get directions
79 Ayer Rajah Crescent
05-03
Singapore, 139955, SG
-
Get directions
100 Tras Street
09-01 100AM
Downtown Core, Central Region 079027, SG
Employees at REVIVO BioSystems
-
Jenny Chew
From the Boardroom to Breakthroughs; Co-Founder at KittyKat | Former Corporate Leader | Board & Advisory | Executive Coach | Championing AI-Driven…
-
Dr. Bert Grobben
CEO & Strategic Growth Catalyst | Venture Builder & Open Innovation Expert | Driving Profitable Innovation, Strategic Foresight, and AI-driven…
-
Jahan Rezai
Director, Motion & Jupiter 57
-
Massimo Alberti
CEO at REVIVO BioSystems | Microfluidics and Organ-On-a-Chip expert | Biomedical Engineer
Updates
-
𝗦𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗥𝗲𝗹𝗲𝗚𝗢 𝗜𝗻𝘀𝘁𝗮𝗹𝗹𝗮𝘁𝗶𝗼𝗻 & 𝗧𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗮𝘁 Singapore Polytechnic! 🔬 Happy to contribute to the 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲 𝗽𝗿𝗲-𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗰𝗼𝘀𝗺𝗲𝘁𝗶𝗰𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗲𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺 with the installation and training of our 𝗥𝗲𝗹𝗲𝗚𝗢 𝗺𝗶𝗰𝗿𝗼𝗳𝗹𝘂𝗶𝗱𝗶𝗰𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 at Singapore Polytechnic! 🦠 Our 𝗥𝗲𝗹𝗲𝗚𝗢 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 empowers researchers to conduct 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗽𝗲𝗿𝗺𝗲𝗮𝘁𝗶𝗼𝗻 𝘁𝗲𝘀𝘁𝘀 and 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗰𝘂𝗹𝘁𝘂𝗿𝗲𝘀 𝗳𝗼𝗿 𝘀𝗸𝗶𝗻 𝗲𝘅𝗽𝗹𝗮𝗻𝘁𝘀. We're thrilled to see how the team at Singapore Polytechnic will leverage this technology to push the boundaries of their research. 🙏 A big thank you to Singapore Polytechnic and SP Consumer Chemicals Technology Centre (CCTC) for their fantastic collaboration! We look forward to seeing the innovative discoveries that emerge from their work with 𝗥𝗲𝗹𝗲𝗚𝗢. #MicrofluidicsSolutions #SkinCareResearch #RND #SingaporeScience #InnovationInResearch
-
-
🏙️ 𝗦𝘂𝗽𝗽𝗹𝗶𝗲𝗿𝘀' 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 has concluded, and what a fantastic journey it was! 🧫 Showcasing our innovative 𝗺𝗶𝗰𝗿𝗼𝗳𝗹𝘂𝗶𝗱𝗶𝗰𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 and 𝗼𝗿𝗴𝗮𝗻-𝗼𝗻-𝗰𝗵𝗶𝗽𝘀 at this event was incredibly rewarding. Thank you to everyone who visited our booth and made it such a success. 🔗 𝗦𝘁𝗮𝘆 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱! Follow us to track our advancements and future initiatives.
-
-
🎉 What an exceptional first day at 𝗦𝘂𝗽𝗽𝗹𝗶𝗲𝗿𝘀' 𝗗𝗮𝘆 𝗡𝗬𝗖 𝟮𝟬𝟮𝟱! 🚀 Our Booth 1478 was buzzing with activity, and we were especially thrilled by the strong interest from 𝗴𝗹𝗼𝗯𝗮𝗹 𝗖𝗥𝗢𝘀 𝗮𝗻𝗱 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗰𝗼𝘀𝗺𝗲𝘁𝗶𝗰𝘀 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀. It's fantastic to see such enthusiasm for our 𝗺𝗶𝗰𝗿𝗼𝗳𝗹𝘂𝗶𝗱𝗶𝗰𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺! ⏳ There's still time! Don't miss this unique opportunity 𝘁𝗼 𝘃𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁 𝗕𝗼𝗼𝘁𝗵 𝟭𝟰𝟳𝟴 and discover how our solutions can transform your preclinical research.
-
-
🎉 The countdown is on! Only 𝟰 𝗱𝗮𝘆𝘀 𝘂𝗻𝘁𝗶𝗹 𝗦𝘂𝗽𝗽𝗹𝗶𝗲𝗿𝘀' 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 𝗼𝗽𝗲𝗻𝘀! Are you a 𝗰𝗼𝘀𝗺𝗲𝘁𝗶𝗰𝘀, 𝘄𝗼𝘂𝗻𝗱 𝗰𝗮𝗿𝗲, 𝗼𝗿 𝗽𝗵𝗮𝗿𝗺𝗮 company, or an 𝗶𝗻𝗴𝗿𝗲𝗱𝗶𝗲𝗻𝘁𝘀 𝘀𝘂𝗽𝗽𝗹𝗶𝗲𝗿? Don't miss your chance to meet REVIVO BioSystems! We're shaping the 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗽𝗿𝗲𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗲𝘀𝘁𝗶𝗻𝗴. Come discover our 𝗺𝗶𝗰𝗿𝗼𝗳𝗹𝘂𝗶𝗱𝗶𝗰𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗶𝗻 𝗮𝗰𝘁𝗶𝗼𝗻 𝗮𝘁 𝗕𝗼𝗼𝘁𝗵 𝟭𝟰𝟳𝟴, in partnership with Medelink Enterprise Inc. 🚀 Join the future of pre-clinical testing! 📍 Find us at Booth 1478 - Suppliers’ Day NYSCC 📅 June 3-4, 2025 🏢 Javits Center, New York
-
-
REVIVO BioSystems is excited to participate in 𝗦𝘂𝗽𝗽𝗹𝗶𝗲𝗿𝘀’ 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 𝗶𝗻 𝗡𝗲𝘄 𝗬𝗼𝗿𝗸 𝗖𝗶𝘁𝘆, in partnership with Medelink Enterprise Inc.! Join us on June 3-4 at the Javits Center to explore our cutting-edge 𝗺𝗶𝗰𝗿𝗼𝗳𝗹𝘂𝗶𝗱𝗶𝗰𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 and 𝗼𝗿𝗴𝗮𝗻-𝗼𝗻-𝗮-𝗰𝗵𝗶𝗽 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 for preclinical testing. We empower healthcare companies to generate 𝗿𝗼𝗯𝘂𝘀𝘁 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝘂𝘀𝗶𝗻𝗴 𝗮𝗻𝗶𝗺𝗮𝗹-𝗳𝗿𝗲𝗲 𝗺𝗼𝗱𝗲𝗹𝘀 across 𝗰𝗼𝘀𝗺𝗲𝘁𝗶𝗰𝘀, 𝘄𝗼𝘂𝗻𝗱 𝗰𝗮𝗿𝗲, 𝗮𝗻𝗱 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 industries. 🚀 Join the future of pre-clinical testing! 📍 Find us at 𝗕𝗼𝗼𝘁𝗵 𝟭𝟰𝟳𝟴 - Suppliers’ Day NYSCC 📅 June 3-4, 2025 🏢 Javits Center, New York #revivobiosystems #microfluidics
-
-
This month, we're once again bridging continents with innovation! The ReleGO 4D microfluidics platform is on its way to the USA, sent via our trusted partner Medelink Enterprise Inc., to power a US-based client with cutting-edge in vitro testing capabilities. 🔬
-
-
Proud to support 𝗗𝗘𝗕𝗥𝗔 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲 (Dystrophic Epidermolysis Bullosa Research Association) at today's 𝗙𝘂𝗻𝗱𝗿𝗮𝗶𝘀𝗶𝗻𝗴 𝗚𝗮𝗹𝗮 for rare skin diseases! REVIVO BioSystems is an active participant, with our Head of Ex-vivo & In-vitro Research, Sebastien Teissier, leading a 𝘀𝗽𝗲𝗰𝗶𝗮𝗹 𝗽𝗵𝗼𝘁𝗼𝗯𝗼𝗼𝗸 𝗽𝗿𝗼𝗷𝗲𝗰𝘁 to empower those living with these conditions. We're dedicated to making a difference alongside DEBRA Singapore on Friday, May 2nd, 2025. #SupportRareDiseases #DEBRASingaporeGala #RevivoBioSystems #EmpoweringLives
-
-
Bridging continents with innovation! ✨ Our ReleGO 4D microfluidics platform is heading to the USA, via our trusted partner Medelink Enterprise Inc., ready to empower a US-based client with the future of in vitro testing. 🔬✈ #ReleGO #OrganOnAChip #GlobalReach #Medelink #InnovationInTheUSA
-
-
𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗳𝗼𝗿 𝗲𝘅 𝘃𝗶𝘃𝗼 𝗮𝗻𝗱 𝗶𝗻 𝘃𝗶𝘁𝗿𝗼 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵! 🧪 Joining forces with our partner WEPREDIC, this week our 𝗛𝗲𝗮𝗱 𝗼𝗳 𝗘𝘅 𝗩𝗶𝘃𝗼 𝗮𝗻𝗱 𝗜𝗻 𝗩𝗶𝘁𝗿𝗼 𝗧𝗲𝘀𝘁𝗶𝗻𝗴, Sebastien Teissier was in Rennes, France, to lead a successful demo and training on the best practices with 𝗥𝗲𝗹𝗲𝗚𝗢 for WEPREDIC and @SOLA, a renown Japanese company specializing in ex vivo and in vitro efficacy testing of cosmetics. 🧫 The focus? Growing interest in our 𝗥𝗲𝗹𝗲𝗚𝗢 𝟰𝗗 𝗺𝗶𝗰𝗿𝗼𝗳𝗹𝘂𝗶𝗱𝗶𝗰𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺, designed to 𝗺𝗶𝗺𝗶𝗰 𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗺𝗼𝗿𝗲 𝗿𝗲𝗹𝗲𝘃𝗮𝗻𝘁 𝗽𝗿𝗲𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝗶𝗲𝘀. We're proud to be at the forefront of developing solutions that 𝗲𝗺𝗽𝗼𝘄𝗲𝗿 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 with more relevant and predictive in vitro/ ex vivo models. 🔬 Stay tuned for more! If you are interested in a demo session of our ReleGO, reach out to us at sales@revivobio.com or to our distributors around the world https://lnkd.in/grjxgYby. #revivobiosystems #microfluidics #exvivo #invitro #research #ReleGO #Wepredic #SOLA
-